楚天科技(300358.SZ):一季度預虧2300萬元-2800萬元
格隆匯3月27日丨楚天科技(300358.SZ)披露2020年第一季度業績預告,預計歸屬於上市公司股東的淨虧損2300萬元-2800萬元,上年同期盈利637.72萬元。
業績變動原因系2020年一季度,由於新冠肺炎疫情的突然爆發,全國各省、市相繼啟動了重大突發公共衞生事件一級響應,全國各地均採取了多種手段防控疫情。受疫情影響,公司下游企業復工復產延緩,藥企提貨延期,導致公司設備交付調試進度放緩,當期銷售收入大幅減少,給公司一季度經營業績造成了重大影響。
2020年一季度非經常性損益對淨利潤的影響金額約為980萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.